Expertise, creativity, cooperation
The future of efficacious aerosol therapy lies in optimising drug-to-device and device-to-drug. PARI Pharma has now taken the next step here: it has put the development of formulations, the next generation of aerosol delivery platforms and aerosol characterisation all under one roof. We are currently working on innovative treatment methods and systems for the upper and lower airway as well as eFlow® technology.
